Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Advances in the molecular characterization of multiple myeloma and mechanism of therapeutic resistance.
Journal: Frontiers in oncology
Published: August 15, 2022
Correction: COVID-19 Infections and Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers.
Journal: Blood cancer discovery
Published: October 18, 2021
Carfilzomib and dexamethasone induction with lenalidomide, clarithromycin and dexamethasone consolidation and lenalidomide maintenance for newly diagnosed multiple myeloma.
Journal: American journal of hematology
Published: May 10, 2021
Sequential intensive chemotherapy followed by autologous or allogeneic transplantation for refractory lymphoma.
Journal: Leukemia & lymphoma
Published: February 15, 2021
Plasma Cell Myeloma Presenting With Amyloid-Laden Crystal-Negative Histiocytosis.
Journal: American journal of clinical pathology
Published: July 25, 2020
COVID-19 infections and outcomes in patients with multiple myeloma in New York City: a cohort study from five academic centers.
Journal: medRxiv : the preprint server for health sciences
Published: June 25, 2020
COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers.
Journal: Blood cancer discovery
Published: June 12, 2020
Sequence matters: elotuzumab more effective if used before daratumumab.
Journal: Leukemia & lymphoma
Published: December 18, 2019
High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma.
Journal: Bone marrow transplantation
Published: March 05, 2019
Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myeloma.
Journal: American journal of hematology
Published: October 18, 2018
Last Updated: 09/26/2026